Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important PlayersDániel Sandi, László Vécsei|Molecules|2021Cited by 45
Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitantsZsófia Kokas, Krisztina Bencsik, Dániel Sandi et al.|Multiple Sclerosis and Related Disorders|2022Cited by 5